Thursday, April 5, 2012 | 9:06 a.m. CDT;
updated 9:15 a.m. CDT, Thursday, April 5, 2012
ST. LOUIS — Researchers at Saint Louis University are part of a study looking at an oral drug aimed at helping people with multiple sclerosis.
To read the full article, please sign up or login.
* Unlimited access on your
Android phone and
* All the high-quality, in-depth journalism of the Columbia Missourian and Vox Magazine, updated 24/7
* Your news. Your device. Your time.
If you'd like to read more about the value of being a member, read this column from the Missourian's executive editor, Tom Warhover.